Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses:
Research and development	$ 9,621,505	$ 4,960,515	$ 24,685,505	$ 20,266,965
General and administrative	1,022,050	639,271	3,066,382	1,768,058
Total operating expenses	10,643,555	5,599,786	27,751,887	22,035,023
Loss from operations	(10,643,555)	(5,599,786)	(27,751,887)	(22,035,023)
Other income (expense)
Interest expense	(537,661)	(433,072)	(1,428,108)	(824,283)
Interest income	287,495	5,612	391,301	7,803
Loss on sale of fixed assets				(263)
Other income (expense), net	(250,166)	(427,460)	(1,036,807)	(816,743)
Net loss before income taxes	(10,893,721)	(6,027,246)	(28,788,694)	(22,851,766)
Income tax benefits
Net loss	$ (10,893,721)	$ (6,027,246)	$ (28,788,694)	$ (22,851,766)
Net loss per share, basic and diluted	$ (0.75)	$ (0.41)	$ (1.95)	$ (1.78)
Weighted average common shares outstanding, basic and diluted	14,938,224	14,877,619	14,928,727	12,867,484